Commercialization and regulation of regenerative medicine products: Promises, advances and challenges

MLA

Nima Beheshtizadeh, et al. “Commercialization and Regulation of Regenerative Medicine Products: Promises, Advances and Challenges.” Biomedicine & Pharmacotherapy, vol. 153, no. 113431-, Sept. 2022. EBSCOhost, https://doi.org/10.1016/j.biopha.2022.113431.

APA

Nima Beheshtizadeh, Maliheh Gharibshahian, Zahra Pazhouhnia, Mohammadreza Rostami, Ali Rajabi Zangi, Reza Maleki, Hanieh Kolahi Azar, Vahideh Zalouli, Hosnieh Rajavand, Ali Farzin, Nasrin Lotfibakhshaiesh, Farshid Sefat, Mahmoud Azami, Thomas J. Webster, & Nima Rezaei. (2022). Commercialization and regulation of regenerative medicine products: Promises, advances and challenges. Biomedicine & Pharmacotherapy, 153(113431-). https://doi.org/10.1016/j.biopha.2022.113431

Chicago

Nima Beheshtizadeh, Maliheh Gharibshahian, Zahra Pazhouhnia, Mohammadreza Rostami, Ali Rajabi Zangi, Reza Maleki, Hanieh Kolahi Azar, et al. 2022. “Commercialization and Regulation of Regenerative Medicine Products: Promises, Advances and Challenges.” Biomedicine & Pharmacotherapy 153 (113431-). doi:10.1016/j.biopha.2022.113431.